| Year |
Citation |
Score |
| 2021 |
Onken MD, Makepeace CM, Kaltenbronn KM, Choi J, Hernandez-Aya L, Weilbaecher KN, Piggott KD, Rao PK, Yuede CM, Dixon AJ, Osei-Owusu P, Cooper JA, Blumer KJ. Targeting primary and metastatic uveal melanoma with a G protein inhibitor. The Journal of Biological Chemistry. 100403. PMID 33577798 DOI: 10.1016/j.jbc.2021.100403 |
0.528 |
|
| 2019 |
Meleka MM, Edwards AJ, Xia J, Dahlen SA, Mohanty I, Medcalf M, Aggarwal S, Moeller KD, Mortensen OV, Osei-Owusu P. Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G class G proteins. Pharmacological Research. 141: 264-275. PMID 30634050 DOI: 10.1016/J.Phrs.2019.01.012 |
0.449 |
|
| 2017 |
Kanai SM, Edwards AJ, Rurik JG, Osei-Owusu P, Blumer KJ. Proteolytic degradation of Regulator of G Protein Signaling 2 facilitates temporal regulation of Gq/11 signaling and vascular contraction. The Journal of Biological Chemistry. PMID 28974581 DOI: 10.1074/Jbc.M117.797134 |
0.636 |
|
| 2017 |
Owens EA, Jie L, Reyes BAS, Van Bockstaele EJ, Osei-Owusu P. Elastin insufficiency causes hypertension, structural defects and abnormal remodeling of renal vascular signaling. Kidney International. PMID 28754555 DOI: 10.1016/J.Kint.2017.04.044 |
0.437 |
|
| 2016 |
Jie L, Owens EA, Plante LA, Fang Z, Rensing DT, Moeller KD, Osei-Owusu P. RGS2 squelches vascular Gi/o and Gq signaling to modulate myogenic tone and promote uterine blood flow. Physiological Reports. 4. PMID 26811058 DOI: 10.14814/Phy2.12692 |
0.316 |
|
| 2015 |
Beeman SC, Osei-Owusu P, Duan C, Engelbach J, Bretthorst GL, Ackerman JJH, Blumer KJ, Garbow JR. Renal DCE-MRI Model Selection Using Bayesian Probability Theory. Tomography (Ann Arbor, Mich.). 1: 61-68. PMID 30042955 DOI: 10.18383/j.tom.2015.00133 |
0.52 |
|
| 2015 |
Osei-Owusu P, Owens EA, Jie L, Reis JS, Forrester SJ, Kawai T, Eguchi S, Singh H, Blumer KJ. Regulation of Renal Hemodynamics and Function by RGS2. Plos One. 10: e0132594. PMID 26193676 DOI: 10.1371/Journal.Pone.0132594 |
0.65 |
|
| 2015 |
Osei-Owusu P, Blumer KJ. Regulator of G Protein Signaling 2: A Versatile Regulator of Vascular Function. Progress in Molecular Biology and Translational Science. 133: 77-92. PMID 26123303 DOI: 10.1016/Bs.Pmbts.2015.02.001 |
0.624 |
|
| 2015 |
Osei-Owusu P, Blumer KJ. Regulator of G Protein Signaling 2: A Versatile Regulator of Vascular Function Progress in Molecular Biology and Translational Science. 133: 77-92. DOI: 10.1016/bs.pmbts.2015.02.001 |
0.578 |
|
| 2014 |
Oladipupo SS, Smith C, Santeford A, Park C, Sene A, Wiley LA, Osei-Owusu P, Hsu J, Zapata N, Liu F, Nakamura R, Lavine KJ, Blumer KJ, Choi K, Apte RS, et al. Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 111: 13379-84. PMID 25139991 DOI: 10.1073/Pnas.1324235111 |
0.604 |
|
| 2014 |
Osei-Owusu P, Knutsen RH, Kozel BA, Dietrich HH, Blumer KJ, Mecham RP. Altered reactivity of resistance vasculature contributes to hypertension in elastin insufficiency. American Journal of Physiology. Heart and Circulatory Physiology. 306: H654-66. PMID 24414067 DOI: 10.1152/Ajpheart.00601.2013 |
0.64 |
|
| 2013 |
Li A, Knutsen RH, Zhang H, Osei-Owusu P, Moreno-Dominguez A, Harter TM, Uchida K, Remedi MS, Dietrich HH, Bernal-Mizrachi C, Blumer KJ, Mecham RP, Koster JC, Nichols CG. Hypotension due to Kir6.1 gain-of-function in vascular smooth muscle. Journal of the American Heart Association. 2: e000365. PMID 23974906 DOI: 10.1161/Jaha.113.000365 |
0.583 |
|
| 2012 |
Osei-Owusu P, Sabharwal R, Kaltenbronn KM, Rhee MH, Chapleau MW, Dietrich HH, Blumer KJ. Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling. The Journal of Biological Chemistry. 287: 12541-9. PMID 22354966 DOI: 10.1074/Jbc.M111.332130 |
0.643 |
|
| 2007 |
Osei-Owusu P, Sun X, Drenan RM, Steinberg TH, Blumer KJ. Regulation of RGS2 and second messenger signaling in vascular smooth muscle cells by cGMP-dependent protein kinase. The Journal of Biological Chemistry. 282: 31656-65. PMID 17681944 DOI: 10.1074/Jbc.M706360200 |
0.612 |
|
| 2007 |
Tiniakov R, Osei-Owusu P, Scrogin KE. The 5-hydroxytryptamine1A receptor agonist, (+)-8-hydroxy-2-(di-n-propylamino)-tetralin, increases cardiac output and renal perfusion in rats subjected to hypovolemic shock. The Journal of Pharmacology and Experimental Therapeutics. 320: 811-8. PMID 17085544 DOI: 10.1124/Jpet.106.114355 |
0.646 |
|
| 2006 |
Osei-Owusu P, Scrogin K. Role of the arterial baroreflex in 5-HT1A receptor agonist-mediated sympathoexcitation following hypotensive hemorrhage. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 290: R1337-44. PMID 16397093 DOI: 10.1152/Ajpregu.00671.2005 |
0.688 |
|
| 2005 |
Osei-Owusu P, James A, Crane J, Scrogin KE. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. The Journal of Pharmacology and Experimental Therapeutics. 313: 1324-30. PMID 15743927 DOI: 10.1124/Jpet.104.082073 |
0.666 |
|
| 2004 |
Osei-Owusu P, Scrogin KE. Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage. The Journal of Pharmacology and Experimental Therapeutics. 309: 1132-40. PMID 14769835 DOI: 10.1124/Jpet.103.064626 |
0.694 |
|
| Show low-probability matches. |